Abstract
it is a pioneering approach to the world of academia, radically improving the way scholarly research is managed. The grand vision of Frontiers is a world where all people have an equal opportunity to seek, share and generate knowledge. Frontiers provides immediate and permanent online open access to all its publications, but this alone is not enough to realize our grand goals.
Introduction
The transition from pediatric to adult healthcare represents a critical "transition gap" for young adults with Type 1 Diabetes (T1DM). This period often coincides with the move to university, where the loss of parental oversight and the onset of academic and social pressures frequently lead to medical disengagement and worsening glycemic control. This research collection, published in Frontiers in Endocrinology, explores multi-pronged strategies—ranging from novel pharmacology to advanced "artificial pancreas" algorithms—to bridge this gap.
Addressing the Transition Gap
Standard insulin therapy can be overwhelming for students balancing new responsibilities. The collection aims to identify strategies that are medically effective, scalable, and financially sustainable. By integrating clinical technology with the lived reality of college life, researchers seek to reduce the risk of long-term complications and hospitalizations during this high-risk developmental phase.
Methodological Overview
The research utilizes diverse methodologies to tackle diabetes management from multiple angles:
- Pharmacological Testing: Evaluation of synergistic drug combinations (GABA, sitagliptin, and omeprazole) in Non-Obese Diabetic (NOD) mouse models.
- Clinical Trials: Single-blind, randomized crossover trials comparing single-hormone (insulin) vs. dual-hormone (insulin + glucagon) closed-loop systems in adolescents.
- In-Silico Evaluation: Stress-testing intelligent "artificial pancreas" controllers using the FDA-approved UVA/Padova T1DM simulator.
- Financial Modeling: Assessing the economic sustainability of remote patient monitoring (RPM) in pediatric clinics.
- Meta-Analysis: Systematic review of parental mental health across 10 countries.
Key Insights and Innovations
Triple Therapy Synergy
Research by Lagunas-Rangel et al. suggests that a combination of GABA, a DPP-4 inhibitor, and a proton pump inhibitor (PPI) is more effective at preventing and reversing diabetes in mouse models than double-drug combinations. This "triple therapy" could provide a low-cost, oral adjunct to traditional insulin.
The Dual-Hormone Paradox
Contrary to expectations, Lindkvist et al. found that dual-hormone systems (insulin + glucagon) were less efficient than insulin-only systems for adolescents, particularly during overnight periods. This underscores the complexity of tuning hormonal algorithms for active younger populations.
Predictive Indicators and Financial Viability
- Waist-Height Ratio (WHtR): Sheng et al. identified WHtR as a more stable long-term predictor of diabetes (6-12 years) compared to standard waist circumference.
- Remote Monitoring: Financial modeling by Dupenloup et al. indicates that remote monitoring can be revenue-neutral for clinics even with modest reimbursement rates, supporting the scalability of tech-enabled care.
Key Results
- Artificial Pancreas Performance: New controllers achieved a Time-in-Range (TIR) of 86.0% ± 5.8% in-silico without requiring manual meal announcements.
- Parental Mental Health: Approximately 22.4% of parents of children with T1DM suffer from depression, with mothers (31.5%) being disproportionately affected.
- Early Screening: Markers for diabetic complications, such as dyslipidemia, were observed in children as young as 11 years old, highlighting the need for early intervention.
Future Directions
While results are promising, several challenges remain. The transition from mouse models to human clinical trials is a primary hurdle. Additionally, while "artificial pancreas" systems show potential, real-world variability and the accessibility of Continuous Glucose Monitors (CGMs) for under-insured populations must be addressed. Future research will focus on non-insulin alternatives, microbiome regulation, and tailored psychosocial support for the university environment.
Summary updated